CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 87 filers reported holding CUREVAC N V in Q4 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,759 | -34.0% | 23,830 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $246,746 | +130.0% | 23,680 | +53.9% | 0.00% | – |
| Q1 2023 | $107,261 | +13.0% | 15,389 | -2.2% | 0.00% | – |
| Q4 2022 | $94,900 | -23.5% | 15,738 | -0.2% | 0.00% | – |
| Q3 2022 | $124,000 | -37.4% | 15,770 | +8.3% | 0.00% | -100.0% |
| Q2 2022 | $198,000 | -47.9% | 14,566 | -24.8% | 0.00% | 0.0% |
| Q1 2022 | $380,000 | -57.9% | 19,377 | -26.4% | 0.00% | -50.0% |
| Q4 2021 | $903,000 | – | 26,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |